IBAKWIK

This brand name is authorized in Nigeria.

Active ingredients

The drug IBAKWIK contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 9RMU91N5K2 - ARTEMISININ
 

Artemisinin is used in the treatment of malaria due to species Plasmodium.
 
Read more about Artemisinin
2
UNII 854D7K8LXB - PIPERAQUINE PHOSPHATE
 
Read more about

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-101104 Capsule Ibakwik Softgel CAP 62.5 mg; 375 mg 1 x 10's (in blister) Capsule Soft gelatin capsule 22/11/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P01BF05 Artenimol and piperaquine P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-101104

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈